Investment Thesis
HealthLynked faces imminent financial distress with negative stockholders' equity of -$5.8M, only $37.1K cash reserves, and operating cash burn of -$1.7M annually. Revenue collapsed 31.3% YoY while the company burns cash at a rate that depletes remaining liquidity in approximately 3 weeks, creating acute solvency risk.
Strengths
- Exceptional gross margin of 90.7% demonstrates viable core unit economics in medical services delivery
- Net loss improved 46.5% YoY suggesting operational cost controls are taking effect
- Healthcare services sector has structural demand tailwinds if company survives liquidity crisis
Risks
- Negative equity of -$5.8M means liabilities exceed all assets - company is technically insolvent
- Critical liquidity crisis: $37.1K cash against $7.5M liabilities with monthly burn rate exceeding available cash
- Severe revenue decline of 31.3% YoY with no evidence of stabilization or recovery trajectory
- Negative operating cash flow of -$1.7M and free cash flow margin of -83.1% indicate unsustainable operations
- Current ratio of 0.22x shows inability to service short-term obligations from current assets
Key Metrics to Watch
- Monthly cash burn rate and estimated runway to insolvency/capital injection deadline
- Revenue trend reversal: Whether next quarter stabilizes the -31% YoY decline
- Operating cash flow return to positive: Critical survival metric given current burn
- Capital raise or debt restructuring announcements to address negative equity
- Customer acquisition cost versus lifetime value trends in medical services segment
Financial Metrics
Revenue
2.1M
Net Income
-3.3M
EPS (Diluted)
$-1.16
Free Cash Flow
-1.7M
Total Assets
1.7M
Cash
37.1K
Profitability Ratios
Gross Margin
90.7%
Operating Margin
-102.3%
Net Margin
-158.8%
ROE
N/A
ROA
-192.7%
FCF Margin
-83.1%
Balance Sheet & Liquidity
Current Ratio
0.22x
Quick Ratio
0.22x
Debt/Equity
N/A
Debt/Assets
438.5%
Interest Coverage
-349.53x
Long-term Debt
450.0K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-11T05:39:24.370323 |
Data as of: 2025-12-31 |
Powered by Claude AI